202 related articles for article (PubMed ID: 23715180)
1. [Effect of maggot therapy on minimally necrotic tissues: characterization of larval enzymatic excretion/secretion].
Téllez GA; Acero MA; Pineda LA; Castaño JC
Biomedica; 2012 Sep; 32(3):312-20. PubMed ID: 23715180
[TBL] [Abstract][Full Text] [Related]
2. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy.
Sherman RA
Diabetes Care; 2003 Feb; 26(2):446-51. PubMed ID: 12547878
[TBL] [Abstract][Full Text] [Related]
3. Maggot debridement therapy in chronic wound care.
Chan DC; Fong DH; Leung JY; Patil NG; Leung GK
Hong Kong Med J; 2007 Oct; 13(5):382-6. PubMed ID: 17914145
[TBL] [Abstract][Full Text] [Related]
4. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.
Linger RJ; Belikoff EJ; Yan Y; Li F; Wantuch HA; Fitzsimons HL; Scott MJ
BMC Biotechnol; 2016 Mar; 16():30. PubMed ID: 27006073
[TBL] [Abstract][Full Text] [Related]
5. Is larval (maggot) debridement effective for removal of necrotic tissue from chronic wounds?
Gray M
J Wound Ostomy Continence Nurs; 2008; 35(4):378-84. PubMed ID: 18635985
[TBL] [Abstract][Full Text] [Related]
6. Maximising the secondary beneficial effects of larval debridement therapy.
Pritchard DI; Nigam Y
J Wound Care; 2013 Nov; 22(11):610-11, 614-6. PubMed ID: 24225601
[TBL] [Abstract][Full Text] [Related]
7. Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata.
Telford G; Brown AP; Rich A; English JS; Pritchard DI
Med Vet Entomol; 2012 Sep; 26(3):291-9. PubMed ID: 22620282
[TBL] [Abstract][Full Text] [Related]
8. [Maggot therapy in wound management].
Falch BM; de Weerd L; Sundsfjord A
Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1864-7. PubMed ID: 19844278
[TBL] [Abstract][Full Text] [Related]
9. Wound care in venous ulcers.
Mosti G
Phlebology; 2013 Mar; 28 Suppl 1():79-85. PubMed ID: 23482540
[TBL] [Abstract][Full Text] [Related]
10. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.
Tantawi TI; Gohar YM; Kotb MM; Beshara FM; El-Naggar MM
J Wound Care; 2007 Oct; 16(9):379-83. PubMed ID: 17987750
[TBL] [Abstract][Full Text] [Related]
11. Reappraisal and updated review of maggot debridement therapy in chronic lower extremity ulcers.
Shamloul G; Khachemoune A
Int J Dermatol; 2023 Jul; 62(7):962-968. PubMed ID: 36880424
[TBL] [Abstract][Full Text] [Related]
12. Chronic foot ulcer management using maggot debridement and topical negative pressure therapy.
Brin YS; Mumcuoglu KY; Massarwe S; Wigelman M; Gross E; Nyska M
J Wound Care; 2007 Mar; 16(3):111-3. PubMed ID: 17385586
[No Abstract] [Full Text] [Related]
13. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.
Gilead L; Mumcuoglu KY; Ingber A
J Wound Care; 2012 Feb; 21(2):78, 80, 82-85. PubMed ID: 22584527
[TBL] [Abstract][Full Text] [Related]
14. Maggot debridement therapy: a systematic review.
Shi E; Shofler D
Br J Community Nurs; 2014 Dec; Suppl Wound Care():S6-13. PubMed ID: 25478859
[TBL] [Abstract][Full Text] [Related]
15. Maggots as a wound debridement agent for chronic venous leg ulcers under graduated compression bandages: A randomised controlled trial.
Davies CE; Woolfrey G; Hogg N; Dyer J; Cooper A; Waldron J; Bulbulia R; Whyman MR; Poskitt KR
Phlebology; 2015 Dec; 30(10):693-9. PubMed ID: 25300315
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the efficacy of larva therapy for debridement and control of bacterial burden compared to surgical debridement and topical application of an antimicrobial].
Contreras-Ruiz J; Fuentes-Suárez A; Arroyo-Escalante S; Moncada-Barron D; Sosa-de-Martínez MC; Maravilla-Franco E; Domínguez-Cherit JG
Gac Med Mex; 2016 Oct; 152(Suppl 2):78-87. PubMed ID: 27792719
[TBL] [Abstract][Full Text] [Related]
17. Changing attitudes toward maggot debridement therapy in wound treatment: a review and discussion.
King C
J Wound Care; 2020 Feb; 29(Sup2c):S28-S34. PubMed ID: 32058840
[TBL] [Abstract][Full Text] [Related]
18. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.
Paul AG; Ahmad NW; Lee HL; Ariff AM; Saranum M; Naicker AS; Osman Z
Int Wound J; 2009 Feb; 6(1):39-46. PubMed ID: 19291114
[TBL] [Abstract][Full Text] [Related]
19. Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study.
Lullove EJ
Wounds; 2017 Apr; 29(4):107-114. PubMed ID: 28448264
[TBL] [Abstract][Full Text] [Related]
20. Larval therapy for leg ulcers (VenUS II): randomised controlled trial.
Dumville JC; Worthy G; Bland JM; Cullum N; Dowson C; Iglesias C; Mitchell JL; Nelson EA; Soares MO; Torgerson DJ;
BMJ; 2009 Mar; 338():b773. PubMed ID: 19304577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
